Skip to content

Ceres Pharmaceuticals: what changed

BE 0407.326.754NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€2.6m
2024 · -€99,159+€2.7m
Equity
€1.3m
2024 · €2.7m-€1.4m
Cash
€39,350
2024 · €1.2m-€1.1m
Balance sheet total
€9.5m
2024 · €4.7m+€4.7m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€6.0m

    up €6.0m (+460%), from €1.3m to €7.3m

    of which Other amounts receivable: +€5.4m

  • Cash -€1.1m

    down €1.1m (-96.6%), from €1.2m to €39,350

    mainly Receivables within one year (-€6.0m) and Contributions, distributions and other (-€4.0m)

Equity and liabilities
  • Other debts +€4.0m

    up €4.0m (+4,705%), from €84,971 to €4.1m

  • Profit (loss) carried forward -€1.4m

    down €1.4m (-86.2%), from €1.6m to €218,968

  • Trade debts +€1.2m

    up €1.2m (+101%), from €1.2m to €2.4m

  • Tax, wage and social debts +€947,368

    up €947,368 (+166%), from €569,756 to €1.5m

    of which Taxes: +€972,640

Income statement
  • Turnover +€2.1m

    up €2.1m (+17.1%), from €12.5m to €14.6m

  • Goods and materials -€2.1m

    down €2.1m (-28.9%), from €7.2m to €5.1m

    of which Purchases: -€2.9m

  • Taxes +€932,378

    up €932,378 (+12,496%), from €7,462 to €939,839

  • Services and other goods +€821,823

    up €821,823 (+27.8%), from €3.0m to €3.8m

  • Other operating income +€576,430

    up €576,430 (+267%), from €215,939 to €792,369

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€99,159
Turnover +€2.1m
Other operating income +€576,430
Goods and materials +€2.1m
Services and other goods -€821,823
Staff costs +€228,765
Depreciation +€19,583
Write-downs +€55,067
Other operating charges -€94,479
Other operating items -€500,199
Financial income -€43,219
Financial charges +€51,859
Taxes -€932,378
Result 2025 €2.6m
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€2.9m
Investment -€22,379
Financing -€4.0m
Cash 2024 €1.2m
Net result for the year +€2.6m
Depreciation +€3,707
Stocks and contracts +€90,504
Receivables within one year -€6.0m
Deferred charges and accrued income +€72,047
Trade debts +€1.2m
Tax, wage and social debts +€947,368
Other debts +€4.0m
Accrued charges and deferred income -€48,358
Investment in fixed assets (net) -€22,379
Short-term financial debts -€3,175
Contributions, distributions and other -€4.0m
Cash 2025 €39,350
brings cash intakes cash out
Every line side by side 68 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,729,792 €9,461,050 +€4.7m +100%
Fixed assets 21/28 €25,336 €44,008 +€18,672 +73.7%
Tangible fixed assets 22/27 €17,136 €35,948 +€18,812 +110%
Plant, machinery and equipment 23 - €20,278 +€20,278
Furniture and vehicles 24 €17,136 €15,670 -€1,467 -8.6%
Financial fixed assets 28 €8,200 €8,060 -€140 -1.7%
Other financial fixed assets 284/8 €8,200 €8,060 -€140 -1.7%
Amounts receivable and cash guarantees 285/8 €8,200 €8,060 -€140 -1.7%
Current assets 29/58 €4,704,456 €9,417,042 +€4.7m +100%
Stocks and contracts in progress 3 €2,129,335 €2,038,831 -€90,504 -4.3%
Stocks 30/36 €2,129,335 €2,038,831 -€90,504 -4.3%
Raw materials and consumables 30/31 €13,354 - -€13,354
Goods purchased for resale 34 €2,075,501 €2,038,831 -€36,671 -1.8%
Advance payments 36 €40,479 - -€40,479
Amounts receivable within one year 40/41 €1,303,283 €7,302,773 +€6.0m +460%
Trade receivables 40 €1,282,881 €1,893,213 +€610,332 +47.6%
Other amounts receivable 41 €20,402 €5,409,560 +€5.4m +26,415%
Cash at bank and in hand 54/58 €1,163,703 €39,350 -€1.1m -96.6%
Deferred charges and accrued income 490/1 €108,136 €36,088 -€72,047 -66.6%
Total equity and liabilities 10/49 €4,729,792 €9,461,050 +€4.7m +100%
Equity 10/15 €2,681,964 €1,318,968 -€1.4m -50.8%
Contributions 10/11 €1,000,000 €1,000,000 = 0.0%
Capital 10 €1,000,000 €1,000,000 = 0.0%
Issued capital 100 €1,000,000 €1,000,000 = 0.0%
Reserves 13 €100,000 €100,000 = 0.0%
Non-distributable reserves 130/1 €100,000 €100,000 = 0.0%
Legal reserve 130 €100,000 €100,000 = 0.0%
Profit (loss) carried forward 14 €1,581,964 €218,968 -€1.4m -86.2%
Amounts payable 17/49 €2,047,828 €8,142,082 +€6.1m +298%
Amounts payable within one year 42/48 €1,850,747 €7,993,359 +€6.1m +332%
Financial debts 43 €3,175 - -€3,175
Credit institutions 430/8 €3,175 - -€3,175
Trade debts 44 €1,192,846 €2,393,099 +€1.2m +101%
Suppliers 440/4 €1,192,846 €2,393,099 +€1.2m +101%
Taxes, remuneration and social security 45 €569,756 €1,517,124 +€947,368 +166%
Taxes 450/3 €50,126 €1,022,766 +€972,640 +1,940%
Remuneration and social security 454/9 €519,630 €494,358 -€25,271 -4.9%
Other amounts payable 47/48 €84,971 €4,083,136 +€4.0m +4,705%
Accrued charges and deferred income 492/3 €197,081 €148,723 -€48,358 -24.5%
Operating income 70/76A €12,693,379 €15,380,871 +€2.7m +21.2%
Turnover 70 €12,451,609 €14,578,548 +€2.1m +17.1%
Other operating income 74 €215,939 €792,369 +€576,430 +267%
Non-recurring operating income 76A €25,831 €9,955 -€15,876 -61.5%
Operating charges 60/66A €12,768,135 €11,795,728 -€972,407 -7.6%
Goods for resale, raw materials and consumables 60 €7,167,121 €5,097,503 -€2.1m -28.9%
Purchases 600/8 €7,884,655 €4,999,393 -€2.9m -36.6%
Change in stocks: decrease (increase) 609 -€717,535 €98,110 +€815,645
Services and other goods 61 €2,951,776 €3,773,599 +€821,823 +27.8%
Remuneration, social security and pensions 62 €2,626,010 €2,397,245 -€228,765 -8.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,290 €3,707 -€19,583 -84.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€1,257 -€56,324 -€55,067 -4,382%
Other operating charges 640/8 €1,196 €95,675 +€94,479 +7,903%
Non-recurring operating charges 66A - €484,323 +€484,323
Operating profit (loss) 9901 -€74,757 €3,585,144 +€3.7m
Financial income 75/76B €53,771 €10,552 -€43,219 -80.4%
Recurring financial income 75 €53,771 €10,552 -€43,219 -80.4%
Income from financial fixed assets 750 - €10,552 +€10,552
Income from current assets 751 €52,265 - -€52,265
Other financial income 752/9 €1,507 €0 -€1,507 -100.0%
Financial charges 65/66B €70,712 €18,852 -€51,859 -73.3%
Recurring financial charges 65 €70,712 €18,852 -€51,859 -73.3%
Debt charges 650 €63,069 €14,669 -€48,399 -76.7%
Other financial charges 652/9 €7,643 €4,183 -€3,460 -45.3%
Profit (loss) for the period before taxes 9903 -€91,697 €3,576,843 +€3.7m
Income taxes 67/77 €7,462 €939,839 +€932,378 +12,496%
Taxes 670/3 €7,462 €939,839 +€932,378 +12,496%
Profit (loss) for the period 9904 -€99,159 €2,637,004 +€2.7m
Profit (loss) for the period to be appropriated 9905 -€99,159 €2,637,004 +€2.7m

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€3.9m to €5.2m

Midpoint €4.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.3m
Capitalised earnings €6.5m to €9.1m
Indication €3.9m to €5.2m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,318,968
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.3m

Capitalised earnings

net result for the year (9904)
2025
€2,637,004
excluding non-recurring income and charges
€3,111,372
2024
-€99,159
excluding non-recurring income and charges
-€124,989
2023
-€300,447
excluding non-recurring income and charges
-€256,826
2022
€278,373
excluding non-recurring income and charges
€279,082
2021
€644,824
Average result, excluding non-recurring income and charges
€909,852
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€6.5m / €7.6m / €9.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.